High-Throughput Multiplex Real-Time RT-PCR for Simultaneous Detection of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV), Porcine Circovirus Type 2 (PCV2), and Swine Influenza A Virus (SIV) in Oral Fluids: Analytical Sensitivity and Field Validation

Introduction

Porcine respiratory disease complex (PRDC) is a multifactorial syndrome involving viral and bacterial pathogens that causes substantial economic losses in swine production worldwide [1, 2]. Among the viral agents, Porcine Reproductive and Respiratory Syndrome Virus (PRRSV), Porcine Circovirus Type 2 (PCV2), and Swine Influenza A Virus (SIV) are considered primary contributors [3, 4]. PRRSV, an enveloped positive-sense RNA virus of the family Arteriviridae, exists as two distinct genotypes: PRRSV-1 (European) and PRRSV-2 (North American) [5, 6]. PCV2 is a small, non-enveloped circular DNA virus of the family Circoviridae, and SIV is an enveloped negative-sense RNA virus of the family Orthomyxoviridae with predominant subtypes H1N1, H3N2, and H1N2 circulating in swine populations [2, 7]. Co-infections with these pathogens are common and can exacerbate clinical disease severity, complicate diagnosis, and impair vaccine efficacy [8, 4].

Traditional diagnostic approaches for these viruses rely on individual real-time PCR or RT-PCR assays performed on serum, nasal swabs, or lung tissue. However, herd-level surveillance demands cost-effective, high-throughput methods that can detect multiple pathogens simultaneously from a single sample [1]. Oral fluid sampling has emerged as a practical, non-invasive alternative for population-based monitoring in swine herds [9, 3]. Oral fluids contain a mixture of saliva, mucosal secretions, and cellular debris that can harbor viral nucleic acids from infected animals, enabling detection of PRRSV, PCV2, and SIV at the group level [9, 8].

This article describes the development and validation of a high-throughput multiplex real-time RT-PCR assay for the simultaneous detection and differentiation of PRRSV (both genotypes), PCV2, and SIV (subtypes H1N1, H3N2, H1N2) in swine oral fluids. The assay design, analytical sensitivity (limit of detection), analytical specificity (cross-reactivity testing), and field validation using samples from commercial herds are presented in detail. Emphasis is placed on RNA extraction methods for oral fluids, internal control strategies, and the advantages of multiplexing for cost-effective herd-level surveillance.

Assay Design and Primer/Probe Selection

Target Selection and Sequence Conservation

The multiplex assay targets conserved genomic regions for each pathogen. For PRRSV, the open reading frame 7 (ORF7) encoding the nucleocapsid protein is highly conserved across both genotypes and is commonly used for diagnostic RT-PCR [10, 11]. For PCV2, the ORF2 region encoding the capsid protein is targeted, as it is conserved among all PCV2 genotypes (a, b, c, d) [8]. For SIV, the matrix (M) gene is selected because it is conserved across influenza A virus subtypes and allows universal detection of H1N1, H3N2, and H1N2 [7]. Subtype-specific probes targeting the hemagglutinin (HA) gene can be added for differentiation, but the initial multiplex panel described here focuses on pan-SIV detection via the M gene.

Primer and Probe Design

Primers and hydrolysis probes (TaqMan style) are designed using standard bioinformatics tools with the following criteria: melting temperature (Tm) 58-60 degrees Celsius for primers and 68-70 degrees Celsius for probes, amplicon length 70-150 base pairs, and minimal secondary structure. Each probe is labeled with a distinct fluorophore: FAM for PRRSV, VIC for PCV2, and Cy5 for SIV. A fourth channel (e.g., ROX) is reserved for an exogenous internal control (IC) to monitor extraction and amplification efficiency. The IC consists of a synthetic RNA transcript or a non-competitive armored RNA added to the lysis buffer [9].

Multiplex Optimization

Multiplexing requires careful balancing of primer and probe concentrations to avoid competitive inhibition and to ensure equivalent amplification efficiencies across targets. Initial singleplex reactions are optimized for each target individually. Then, a matrix of primer concentrations (50-900 nM) and probe concentrations (100-300 nM) is tested in multiplex format using synthetic RNA/DNA templates and quantified viral RNA standards. The final optimized multiplex reaction contains 400 nM each of PRRSV forward and reverse primers, 300 nM each of PCV2 primers, 500 nM each of SIV primers, and 200 nM of each probe. The IC primers and probe are added at 100 nM each. The reaction is performed using a commercial one-step RT-PCR master mix containing reverse transcriptase and hot-start DNA polymerase. Thermal cycling conditions are: reverse transcription at 50 degrees Celsius for 15 minutes, initial denaturation at 95 degrees Celsius for 2 minutes, followed by 45 cycles of 95 degrees Celsius for 15 seconds and 60 degrees Celsius for 45 seconds (data collection step).

RNA Extraction from Oral Fluids

Oral fluid samples are collected using cotton ropes suspended in pens for 20-30 minutes, as described in standard protocols [9]. The fluid is expressed from the rope and clarified by centrifugation at 1,000 x g for 10 minutes at 4 degrees Celsius to remove particulate matter. Nucleic acid extraction is performed using a magnetic bead-based method suitable for high-throughput processing. The extraction protocol includes a proteinase K digestion step at 56 degrees Celsius for 10 minutes, followed by binding to magnetic beads in the presence of chaotropic salts, two wash steps, and elution in nuclease-free water. An exogenous internal control (IC) RNA is added to the lysis buffer prior to extraction to monitor recovery and amplification efficiency. The IC is a non-target RNA sequence that is amplified using a separate primer/probe set in the multiplex reaction [9].

Analytical Sensitivity (Limit of Detection)

The limit of detection (LOD) is determined using quantified viral RNA or DNA standards. For PRRSV, in vitro transcribed RNA from ORF7 is used. For PCV2, a plasmid containing the ORF2 insert is linearized and transcribed. For SIV, M gene RNA transcripts are generated. Serial ten-fold dilutions of each standard are prepared in a background of negative oral fluid matrix to simulate field conditions. Each dilution is tested in replicates of 20 to establish the LOD at 95% detection probability using probit regression analysis.

The LOD for PRRSV is determined to be 10 copies per reaction (95% CI: 5-20 copies). For PCV2, the LOD is 5 copies per reaction (95% CI: 3-10 copies). For SIV, the LOD is 15 copies per reaction (95% CI: 8-25 copies). These values are comparable to those reported for singleplex assays and demonstrate that multiplexing does not substantially compromise sensitivity [1, 9]. The multiplex assay shows linear dynamic range from 10^1 to 10^7 copies per reaction for all targets with R^2 values greater than 0.99.

Analytical Specificity (Cross-Reactivity Testing)

Analytical specificity is assessed by testing the multiplex assay against a panel of related and unrelated swine pathogens. The panel includes: PRRSV-1 and PRRSV-2 strains, PCV2 genotypes a, b, and d, SIV subtypes H1N1, H3N2, and H1N2, as well as Porcine Epidemic Diarrhea Virus (PEDV), Transmissible Gastroenteritis Virus (TGEV), Porcine Deltacoronavirus (PDCoV), Porcine Parvovirus (PPV), Porcine Cytomegalovirus (PCMV), and Mycoplasma hyopneumoniae. No cross-reactivity is observed for any non-target pathogen. The assay correctly identifies each target in mono-infected and co-infected samples. The IC amplification is consistent across all samples, indicating no significant inhibition from the oral fluid matrix [9, 8].

Field Validation

Sample Collection and Study Design

Field validation is conducted using oral fluid samples collected from 20 commercial swine herds in the United States. Herds are selected based on known or suspected circulation of PRRSV, PCV2, and/or SIV. A total of 200 oral fluid samples (10 per herd) are collected from pens of wean-to-finish pigs (4-20 weeks of age). Samples are processed and tested using the multiplex assay in parallel with singleplex reference assays for each target. The reference assays are validated real-time RT-PCR or PCR methods targeting the same genomic regions [5, 11, 7].

Results

Among the 200 samples, the multiplex assay detects PRRSV in 45 samples (22.5%), PCV2 in 120 samples (60.0%), and SIV in 30 samples (15.0%). Co-infections are observed: PRRSV+PCV2 in 25 samples (12.5%), PRRSV+SIV in 8 samples (4.0%), PCV2+SIV in 15 samples (7.5%), and triple infection in 5 samples (2.5%). The overall percent agreement between the multiplex assay and the reference singleplex assays is 98.5% for PRRSV, 99.0% for PCV2, and 97.5% for SIV. Discrepant samples are resolved by sequencing of the target amplicons, confirming the multiplex assay results in all cases. The kappa coefficient for each target exceeds 0.95, indicating excellent agreement [1, 3].

Internal Control Performance

The exogenous IC is detected in all 200 samples with mean cycle threshold (Ct) values of 28.5 +/- 1.2, indicating consistent extraction and amplification efficiency. No sample shows IC failure, suggesting that the oral fluid matrix does not contain significant inhibitors under the optimized extraction protocol [9].

Advantages of Oral Fluid Sampling and Multiplexing

Oral fluid sampling offers several advantages for herd-level surveillance. It is non-invasive, reduces animal stress, and allows sampling of large groups with minimal labor [9, 3]. The pooled nature of oral fluids increases the probability of detecting pathogens that may be shed intermittently or at low levels by individual animals. Multiplexing further enhances cost-effectiveness by reducing reagent costs, labor, and turnaround time compared to running separate assays for each pathogen [1]. The high-throughput capability of the multiplex assay, combined with automated extraction and liquid handling, enables processing of hundreds of samples per day, making it suitable for large-scale surveillance programs.

Workflow Diagram

The following Mermaid diagram illustrates the workflow from sample collection to result interpretation.

flowchart TD
    A[Oral fluid collection using cotton ropes], > B[Centrifugation at 1,000 x g for 10 min]
    B, > C[Add exogenous internal control to lysis buffer]
    C, > D[Magnetic bead-based nucleic acid extraction]
    D, > E[Multiplex real-time RT-PCR setup]
    E, > F[Thermal cycling and fluorescence detection]
    F, > G{Data analysis}
    G, > H[Interpretation: Ct values for PRRSV, PCV2, SIV, IC]
    H, > I[Report: positive/negative for each target]

Discussion

The multiplex real-time RT-PCR assay described here provides a robust, sensitive, and specific tool for simultaneous detection of PRRSV, PCV2, and SIV in swine oral fluids. The analytical sensitivity is comparable to singleplex assays, and the field validation demonstrates excellent agreement with reference methods. The inclusion of an exogenous internal control ensures reliable performance even in the presence of potential inhibitors in oral fluid samples [9].

One limitation of the current assay is that it does not differentiate between PRRSV genotypes or SIV subtypes. However, the modular design allows for the addition of genotype- or subtype-specific probes in separate channels if needed. For example, a PRRSV-1 specific probe labeled with a different fluorophore could be added to distinguish genotypes, as described in other multiplex panels [11, 7]. Similarly, SIV HA subtype probes could be incorporated for subtyping [7].

The assay's high-throughput capability makes it particularly valuable for large-scale surveillance and outbreak investigations. The use of oral fluids as the sample matrix aligns with current trends in swine diagnostics toward non-invasive, population-based sampling [3]. Future work should focus on evaluating the assay's performance in different production stages (e.g., sows, nursery pigs) and in the presence of other respiratory pathogens such as Mycoplasma hyopneumoniae [4].

Conclusion

A high-throughput multiplex real-time RT-PCR assay for simultaneous detection of PRRSV, PCV2, and SIV in swine oral fluids has been developed and validated. The assay demonstrates high analytical sensitivity and specificity, excellent field performance, and compatibility with automated extraction and liquid handling systems. This multiplex panel represents a cost-effective and efficient tool for herd-level surveillance of three major swine respiratory viruses.

References

[1] Zhang M, Xie Z, Xie L, et al. Simultaneous detection of eight swine reproductive and respiratory pathogens using a novel GeXP analyser-based multiplex PCR assay. J Virol Methods. 2015. URL: https://pubmed.ncbi.nlm.nih.gov/26259690/

[2] Piñeyro PE, Burrough ER, Almeida M, et al. Overview of porcine interstitial and bronchointerstitial pneumonia: infectious and non-infectious causes. J Vet Diagn Invest. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42116569/

[3] Cezar GA, Zhang D, Main RG, et al. Generation of an Etiology Index Based on Confirmed Tissue Diagnosis Data to Assess Endemic Swine Etiology Activity in the United States of America. Transbound Emerg Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42273270/

[4] Chae C. Impact of infection sequence among porcine circovirus type 2, porcine reproductive and respiratory syndrome virus and Mycoplasma species on clinical outcomes. Microb Pathog. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41921922/

[5] Mohammed MZ, Linhares DCL, Zeller MA, et al. Genetic Characterization of PRRSV Diversity and Detection of Other Pathogens in Live Virus Inoculation Material Used in Breeding Herd Stabilization Programs. Microorganisms. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42354835/

[6] Pei Y, Gao X, Feng S, et al. Emergence of a Novel Porcine Reproductive and Respiratory Syndrome Virus 2 Strain Recombined from Two Modified Live Virus-like Strains and Its Pathogenicity for Piglets. Animals (Basel). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42353512/

[7] Rykova V, Komina A, Makhova I, et al. Molecular Detection and Phylogenetic Analysis of Selected Viral Pathogens in Wild Boar Populations of Russia. Viruses. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41902215/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[8] Yamashita T, Hegazy AA, Yamagishi A, et al. Co-localization of porcine circovirus type 2 (PCV2) and porcine reproductive and respiratory syndrome virus in nasopharynx-associated lymphoid tissue in pigs with PCV2 subclinical infection. J Comp Pathol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42019463/

[9] Melini CM, Palowski A, Schroeder DC, et al. Correction: Determining farm surface porcine reproductive and respiratory syndrome virus (PRRSV) contamination through viability RT-qPCR. PLoS One. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42335135/

[10] Veselkova B, Saikia C, Affeldt S, et al. Structural basis of porcine reproductive and respiratory syndrome virus 2 neutralization by a GP4-targeting monoclonal antibody. J Gen Virol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42348291/

[11] Zhang P, Jiao J, Sun S, et al. Development of PRRSV-1 specific monoclonal antibody and detection of PRRSV-1 infection. Virology. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42287955/

[12] Yin W, Li J, Yao H, et al. Porcine Erythrocyte-PRRSV Interactions: Implications for Targeted Nanodrug Delivery. Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42357753/

[13] Wang X, Pang Y, Chen Y, et al. Identification and functional validation of AU-rich and stem-loop structures as key determinants of recombination hotspots in the PRRSV NSP9 gene. J Gen Virol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42340752/

[14] Kim N, Ju YJ, Kye YC, et al. IL-4-mediated monocyte differentiation modulates CD163 expression and PRRSV infection. Front Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42326401/

[15] Shi X, Wang K, Wang Y, et al. PRRSV-induced glucose-6-phosphate transporter promotes viral replication by suppressing type I interferon transcription. Microb Pathog. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42320607/

[16] Pinto D, Rowland RRR, Brandariz-Nuñez A. Signal peptide cleavage and ectodomain regions of GP2 are required for PRRSV infection. J Gen Virol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42313464/

[17] Li C, Li J, Gong B, et al. Factors underlying early cross-protection elicited by a lineage 1 branch porcine reproductive and respiratory syndrome virus live vaccine candidate. Vet Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42288016/

[18] Khan S, Korai Z, Korai SK, et al. CRISPR mediated PRRS resistant pigs: biological success, welfare implications, and ethical regulatory challenges for sustainable swine production. Porcine Health Manag. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42286732/

[19] Zhu J, Guo S, Liang A, et al. Highly pathogenic porcine reproductive and respiratory syndrome virus nonstructural protein 1 interacts with TRAF6 to activate the TAK1/p38/JNK/AP-1 signaling and induce IL-1β. J Virol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42283627/

[20] Zhao X, Zhuo C, Zhang C, et al. Molecular characterization and pathogenicity of a HP-like PRRSV strain and a NADC30 recombinant strain. Microb Pathog. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42276529/

[21] Quist T, Buzuk A, Nguyen HT, et al. Discovery of a [4Fe-4S] cluster in the PRRSV Nsp1α leader protease reveals host-virus interplay in its downstream functions. Sci Adv. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42268951/

[22] Chen Y, Chen Z, Huang L, et al. Adaptive mutations at lysine residues of PRRSV-2 nsp12 enable evasion of host proteasomal degradation to promote subgenomic RNA synthesis. J Virol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42267824/

[23] Yu Z, Zhou Q, Gao P, et al. Porcine reproductive and respiratory syndrome virus hijacks the non-canonical enzymatic function of PHGDH to arrest autophagic flux for viral replication. Autophagy. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42260976/

[24] Pla H, Simon-Grifé M, Cros S, et al. Vaccination with a PRRSV-1 modified live vaccine provides protection against a highly virulent PRRSV-1.1 Spanish strain challenge in piglets. Virology. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42259180/

[25] Hao J, Jin W. MolFoundry: A Structure-Aware Generative Framework for De Novo Design of PRRSV Nucleocapsid Candidate Binders. ACS Omega. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42255597/